Results 11 to 20 of about 2,148,975 (183)

Peripheral T cell lymphoma, not otherwise specified (PTCL‐NOS). A new prognostic model developed by the International T cell Project Network [PDF]

open access: yesBritish Journal of Haematology, 2018
Different models to investigate the prognosis of peripheral T cell lymphoma not otherwise specified (PTCL-NOS) have been developed by means of retrospective analyses.
Massimo Federico   +2 more
exaly   +8 more sources

Microenvironmental immune cell signatures dictate clinical outcomes for PTCL-NOS [PDF]

open access: yesBlood Advances, 2018
Key Points Microenvironmental immune cell signatures stratify PTCL-NOS patients into clinically meaningful disease subtypes. Immune-checkpoint inhibitors represent potential therapeutic options for a PTCL-NOS patient subgroup.
Takeshi Sugio   +2 more
exaly   +5 more sources

DNMT3A mutations define a unique biological and prognostic subgroup associated with cytotoxic T cells in PTCL-NOS.

open access: yesBlood, 2022
Peripheral T-cell lymphomas (PTCLs) are heterogenous T-cell neoplasms often associated with epigenetic dysregulation. We investigated de novo DNA methyltransferase 3A (DNMT3A) mutations in common PTCL entities, including angioimmunoblastic T-cell ...
Herek TA   +26 more
europepmc   +5 more sources

Immune pathway upregulation and lower genomic instability distinguish EBV-positive nodal T/NK-cell lymphoma from ENKTL and PTCL-NOS [PDF]

open access: yesHaematologica, 2022
Primary Epstein-Barr virus (EBV)-positive nodal T/NK-cell lymphoma (PTCL-EBV) is a poorly understood disease which shows features resembling extranodal NK/T-cell lymphoma (ENKTL) and is currently not recognized as a distinct entity but categorized as a ...
Cho Mar Myint Wai   +34 more
doaj   +2 more sources

Peripheral T-cell lymphoma not otherwise specified (PTCL-NOS) [PDF]

open access: yesAtlas of Genetics and Cytogenetics in Oncology and Haematology, 2009
Review on Peripheral T-cell lymphoma not otherwise specified (PTCL-NOS), with data on clinics, and the genes ...
Rigolin, GM   +11 more
core   +4 more sources

Current and upcoming treatment approaches to common subtypes of PTCL (PTCL, NOS; ALCL; and TFHs)

open access: yesBlood
Abstract The treatment of common nodal peripheral T-cell lymphomas (PTCLs), including PTCL, not otherwise specified (PTCL, NOS), anaplastic large-cell lymphomas, and T-follicular helper lymphomas, is evolving.
Alison J Moskowitz   +2 more
exaly   +5 more sources

PTCL‐NOS [PDF]

open access: yesHematological Oncology, 2020
Galectin-1 (Gal-1) has been associated with adverse prognosis in several cancers including lymphoma entities with CD30 expression. However, Gal-1 expression has not been systematically assessed in peripheral T-cell lymphomas (PTCL).
Steiniche, Torben   +21 more
core   +6 more sources

Identification and characterization of peripheral T-cell lymphoma-associated SEREX antigens. [PDF]

open access: yesPLoS ONE, 2011
Peripheral T-cell lymphomas (PTCL) are generally less common and pursue a more aggressive clinical course than B-cell lymphomas, with the T-cell phenotype itself being a poor prognostic factor in adult non-Hodgkin lymphoma (NHL).
Christopher D O Cooper   +6 more
doaj   +3 more sources

Peripheral T-cell lymphoma (PTCL-NOS)

open access: yesActa Haematologica Polonica, 2012
chłoniak z obwodowych komórek T, gdzie indziej niesklasyfikowany, stanowi ok. połowy wszystkich chłoniaków T-komórkowych. Praca prezentuje jego dominującą lokalizację węzłową oraz dość agresywny przebieg kliniczny.
Sułek, Kazimierz
core   +2 more sources

CDKN2A deletion is a frequent event associated with poor outcome in patients with peripheral T-cell lymphoma not otherwise specified (PTCL-NOS) [PDF]

open access: yesHaematologica, 2020
Nodal peripheral T-cell lymphoma not otherwise specified (PTCL-NOS) remains a diagnosis encompassing a heterogenous group of PTCL cases not fitting criteria for more homogeneous subtypes.
Francesco Maura   +37 more
core   +6 more sources

Home - About - Disclaimer - Privacy